Desh Rakshak Aushdhalaya Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Quarterly Results

In 2026, Desh Rakshak Aushdhalaya (DESHRAK) reported revenue ₹8 Cr and net profit ₹1 Cr. Also explore Desh Rakshak Aushdhalaya stock price data download to track price trends across different timeframes.

DESHRAK Quarterly Results — Revenue, Profit & EPS Highlights

Desh Rakshak Aushdhalaya latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Desh Rakshak Aushdhalaya share price chart.

  • Revenue of ₹6 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 20.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.07 in March 2025 (+0.0% vs March 2025)

Desh Rakshak Aushdhalaya Quarterly Results — Revenue, EBITDA, Net Profit & EPS

DESHRAK quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 8 6 6 6 6 33.3% -
Net Profit (₹ Cr) 1 1 0 0 1 - -
EBITDA (₹ Cr) 2 1 1 1 1 - -
EPS (₹) 1.30 1.07 0.96 0.91 1.08 - -
Operating Margin (%) 22.0% 20.0% 21.0% 21.0% 19.0% - -

DESHRAK Share Price Trend — 1-Year Movement Across Quarterly Results

Desh Rakshak Aushdhalaya 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with DESHRAK stock valuation models to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 16.7%
EBITDA Margin 16.7%
Operating Margin 20.0%
ROE (Annual) 10.0%

Balance Sheet Highlights

Total Assets ₹18 Cr
Total Equity ₹10 Cr
Current Assets ₹8 Cr
Current Liabilities ₹3 Cr

Cash Flow Analysis

Operating Cash Flow ₹0 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹0 Cr

DESHRAK vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Desh Rakshak Aushdhalaya latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026
₹442,581.33 Cr 1840.6 15,018 2,710 +1.0% +11.8% 18.0% 162.9
Divis Laboratories
Sept 2025
₹179,470.03 Cr 6756.5 2,860 689 +7.1% - 24.1% 260.2
Torrent Pharmaceuti…
Mar 2026
₹151,833.39 Cr 4572.6 4,111 364 +27.7% +42.2% 8.9% 397.3
Cipla
Mar 2026
₹113,024.67 Cr 1413.9 6,612 543 -14.3% -4.0% 8.2% 205.8
Dr Reddys Laborator…
Mar 2026
₹109,104.54 Cr 1331.4 7,996 221 -12.5% -11.5% 2.8% 502.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores